CUICUI ZHANG: Open Payments
NPI 1518516210 · SANDY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$674 in 42 payments from 15 companies in 2025. Trend: 2023 $199 · 2024 $375 · 2025 $674
Food & beverage: $674
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $189 |
| Vanda Pharmaceuticals Inc. | 3 | $83 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $66 |
| Exact Sciences Corporation | 3 | $51 |
| Gilead Sciences, Inc. | 2 | $48 |
| Alkermes, Inc. | 2 | $42 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 |
| Braeburn Inc. | 2 | $31 |
| Indivior Inc. | 1 | $25 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
Products named: VRAYLAR, FANAPT, CAPLYTA, MAVYRET, Cologuard Collection Kit, ARISTADA, COBENFY, BRIXADI.
Industry payments across UT — which companies pay providers there.
